FOXP1 and cancer: Several of the direct FOXP1 targets upregulated in response to cancer were transcriptional repressors of the circadian clock, including Kfl9, Nr1d1, Per1, and Bhlhe40, providing further evidence that FOXP1 is a negative regulator of clock function in skeletal muscle in response to cancer.